Creative Gross Profit from 2010 to 2025

CELZ Stock

USD 4.97 0.08 1.58%

Creative Medical Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Creative Medical Technology makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2016-06-30

Previous Quarter

-24.5 K

Current Value

0.0

Quarterly Volatility

173.1 K

Covid

Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.7 M, Other Operating Expenses of 6.8 M or Total Operating Expenses of 6.8 M, as well as many indicators such as Price To Sales Ratio of 681, Dividend Yield of 0.0039 or PTB Ratio of 0.76. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.

Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Creative Medical Technology over the last few years. Gross profit is a required income statement account that reflects total revenue of Creative Medical Technology minus its cost of goods sold. It is profit before Creative Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Creative Medical's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 6.6 K

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

Creative Gross Profit Regression Statistics

	Arithmetic Mean	(22,706)
	Geometric Mean	0.00
	Coefficient Of Variation	(891.20)
	Mean Deviation	92,921
	Median	5,400
	Standard Deviation	202,357
	Sample Variance	40.9B
	Range	886.1K
	R-Value	0.15
	Mean Square Error	42.9B
	R-Squared	0.02
	Significance	0.58
	Slope	6,386
	Total Sum of Squares	614.2B

Creative Gross Profit History

	2025	6520.5
	2024	6210.0
	2023	5400.0
	2022	60.1 K
	2021	39.8 K
	2020	113.9 K
	2019	120 K

Other Fundumenentals of Creative Medical Tec

Gross Profit Margin

Creative Medical Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Net Debt	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Long Term Debt	Short Long Term Debt	Intangible Assets	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.6	-0.78	0.74	-0.87	-0.15	1.0	-0.27	-0.85	-0.43	-0.22	0.66	-0.59	0.59	0.65	0.66	0.66	-0.85
Total Stockholder Equity	0.6		-0.03	0.35	-0.54	-0.87	0.62	-0.66	-0.55	-0.7	-0.77	0.98	-0.01	0.0	-0.11	0.99	0.99	-0.45
Retained Earnings	-0.78	-0.03		-0.5	0.72	-0.43	-0.76	-0.17	0.54	-0.04	-0.29	-0.14	0.81	-0.84	-0.94	-0.12	-0.12	0.81
Accounts Payable	0.74	0.35	-0.5		-0.54	0.05	0.74	-0.05	-0.91	-0.12	-0.02	0.29	-0.44	0.43	0.43	0.37	0.37	-0.5
Net Receivables	-0.87	-0.54	0.72	-0.54		0.16	-0.88	0.26	0.57	0.4	0.22	-0.65	0.51	-0.51	-0.52	-0.61	-0.61	0.75
Total Liab	-0.15	-0.87	-0.43	0.05	0.16		-0.17	0.66	0.13	0.61	0.83	-0.82	-0.34	0.36	0.53	-0.83	-0.83	0.05
Total Current Assets	1.0	0.62	-0.76	0.74	-0.88	-0.17		-0.28	-0.86	-0.45	-0.24	0.68	-0.58	0.57	0.63	0.68	0.68	-0.84
Common Stock	-0.27	-0.66	-0.17	-0.05	0.26	0.66	-0.28		0.24	0.6	0.48	-0.64	-0.32	0.24	0.15	-0.63	-0.63	0.3
Net Debt	-0.85	-0.55	0.54	-0.91	0.57	0.13	-0.86	0.24		0.39	0.23	-0.5	0.4	-0.39	-0.47	-0.56	-0.56	0.62
Short Term Debt	-0.43	-0.7	-0.04	-0.12	0.4	0.61	-0.45	0.6	0.39		0.8	-0.7	-0.38	0.42	0.22	-0.66	-0.67	0.09
Current Deferred Revenue	-0.22	-0.77	-0.29	-0.02	0.22	0.83	-0.24	0.48	0.23	0.8		-0.74	-0.47	0.46	0.47	-0.72	-0.72	0.0
Net Tangible Assets	0.66	0.98	-0.14	0.29	-0.65	-0.82	0.68	-0.64	-0.5	-0.7	-0.74		-0.09	0.08	-0.01	0.99	0.99	-0.53
Long Term Debt	-0.59	-0.01	0.81	-0.44	0.51	-0.34	-0.58	-0.32	0.4	-0.38	-0.47	-0.09		-0.95	-0.82	-0.12	-0.11	0.71
Short Long Term Debt	0.59	0.0	-0.84	0.43	-0.51	0.36	0.57	0.24	-0.39	0.42	0.46	0.08	-0.95		0.89	0.1	0.09	-0.8
Intangible Assets	0.65	-0.11	-0.94	0.43	-0.52	0.53	0.63	0.15	-0.47	0.22	0.47	-0.01	-0.82	0.89		-0.02	-0.03	-0.79
Net Invested Capital	0.66	0.99	-0.12	0.37	-0.61	-0.83	0.68	-0.63	-0.56	-0.66	-0.72	0.99	-0.12	0.1	-0.02		1.0	-0.53
Net Working Capital	0.66	0.99	-0.12	0.37	-0.61	-0.83	0.68	-0.63	-0.56	-0.67	-0.72	0.99	-0.11	0.09	-0.03	1.0		-0.52
Capital Stock	-0.85	-0.45	0.81	-0.5	0.75	0.05	-0.84	0.3	0.62	0.09	0.0	-0.53	0.71	-0.8	-0.79	-0.53	-0.52

Click cells to compare fundamentals

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	6.2 K	6.5 K
Gross Profit Margin	0.54	0.34

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC